Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Bretisilocin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gilgamesh Pharma Closes Oversubscribed $60 Million Series A
    Gilgamesh Pharma Closes Oversubscribed $60 Million Series A

    24 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gilgamesh-pharma-closes-oversubscribed-60-million-series-a-to-develop-next-generation-neuropsychiatric-therapies-302723671.html

    PR NEWSWIRE
    24 Mar 2026
    Share Share
    AbbVie Completes Acquisition of Gilgamesh Pharma' Bretisilocin
    AbbVie Completes Acquisition of Gilgamesh Pharma' Bretisilocin

    17 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbvie-completes-acquisition-of-gilgamesh-pharmaceuticals-bretisilocin-302587587.html

    PR NEWSWIRE
    17 Oct 2025
    Share Share
    Enveric Bio Hires IP Firm to Defend Patent Linked to AbbVie Deal
    Enveric Bio Hires IP Firm to Defend Patent Linked to AbbVie Deal

    15 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-15/enveric-biosciences-hires-ip-powerhouse-to-defend-its-us-patent-with-claims-relevant-to-bretisiloc

    PHARMIWEB
    15 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.